Skip to main content
Stem Cell Reports logoLink to Stem Cell Reports
. 2021 Feb 9;16(2):370–371. doi: 10.1016/j.stemcr.2021.01.004

Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis

Xiaofang Wang, Erin A Kimbrel, Kumiko Ijichi, Debayon Paul, Adam S Lazorchak, Jianlin Chu, Nicholas A Kouris, Gregory J Yavanian, Shi-Jiang Lu, Joel S Pachter, Stephen J Crocker, Robert Lanza , Ren-He Xu ∗∗
PMCID: PMC7878825  PMID: 33567293

Main Text

(Stem Cell Reports 3, 115–130; July 8, 2014)

In the originally published version of our paper, the wrong data was used to generate Figure 4A: the hES-MSC line used to generate the figure was not the hES-MSC(MA09) line stated in the figure legend; instead, an hES-MSC line generated via another method, which was not described in the paper, was used. This mistake was uncovered during a recent internal data review.

A correct version of Figure 4 now appears below. The altered figure does not affect the results and conclusion of the paper.

We apologize for the oversight and for any confusion it has caused.

graphic file with name gr4.jpg

Figure 4. Effects of hES-MSCs and BM-MSCs on T Cell Functions In Vitro

Contributor Information

Robert Lanza, Email: rlanza@advancedcell.com.

Ren-He Xu, Email: renhe.xu@imstem.com.


Articles from Stem Cell Reports are provided here courtesy of Elsevier

RESOURCES